Antiretroviral therapy for HIV infection in infants and children : towards universal access : recommendations for a public health approach / WHO - Worl Health Organization
By: WHO - World Health Organization
.
Contributor(s): OMS - Organización Mundial de la Salud (Ginebra).
Series: HIV/AIDS Programme : Strengthening health services to fight HIV/AIDS.Ginebra : WHO - World Health Organization, 2007 Description: iv, 144 p. : tablas ; 24 x 16 cm.ISBN: 92 4 159469 1 -- 978 92 4 159469 1.Subject(s): Agentes antiretrovirales -- farmacología | Agentes antiretrovirales -- terapéutica | Farmacologia y terapeutica | Medicina | Infecciones del vih -- terapia de droga | Terapia antiretroviral | Terapia antiretroviral altamente activa | Terapias | SaludDDC classification: 615.85 / W551a | Item type | Current location | Collection | Call number | Vol info | Copy number | Status | Notes | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|---|---|---|---|
Libros
|
Biblioteca Ciencias de la Salud | FONDO BIBL | 615.85 / W551a (Browse shelf) | 8001 | 1 | Available | DO | 8300004962 |
Objetives of the guidelines -- Development of the guidelines -- Establishing diagnosis of HIV infection -
When to Start Antiretroviral Therapy in Infants and Children -- What to Start - Recommended first-Line ARV
Regimens in Infants and Children -- Considerations for ART in Infants Previously Exposed to ARV Drugs
--Atiretroviral drug Toxicity -- Substituting whithin a First-line ARV Regimen in Infants and CHILDREN because
of Drug Toxicity -- Sitching an ARV Regimen in Infants and Children. Treatment Failure -- Choise of ARV
Regimens in the Event of Treatment Failure of First-Line Regimens in Infants and Children - Second-Line
Regimens -- Considerations for infants and children Coinfected With Tuberculosis and HIV -- Considerations for
Nutrition in HIV-infected Infants and Children -- Considerations for ART in Adolescents -- Clinical and
Laboratory Monitoring -- Adherence to ART -- Strategies in the Event of Failure of Second-Line Regimens --
Drug Resistance -- Members of the technical reference group on paediatric HIV care and treatment -- WHO
clinical staging of HIV for infants and children with established HIV infection -- Presumptive and definitive
criteria for recognizing HIV related clinical events in infants and children with established HIV infection --
WHO classification of HIV-associated immunodeficency in infants and children -- 12 Month mortality risk at
selected thresholds for %CD4+, absolute CD4 count and total lymphocyte count by age -- Prescribing information
and weight based dosing of available ARV formulations for infants and children -- Seroius acute and chronic
toxicities caused by ARV drugs, possibly requiring therapy modification: clinical preenation, laboratory
abnormalities and implications for ART management -- Severity grading of selected clinical and laboratory
toxicities most commonly seen with recommended ARV drugs for children -- Sexual maturity rating (Tanner
staging) in adolescents -- Recommended tiered laboratory capabilities for ART monitoring in resource-limited s
settings -- References --
There are no comments for this item.